findmyKOL
Clinical trialNCT00907452CompletedInterventional

Pharmacogenomic Study in Myeloma Patients Treated With Melphalan-prednisone-thalidomide or Lenalidomide-dexamethasone

SponsorIntergroupe Francophone du MyelomeEnrollment143Myeloma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Ch Albi

    Albi, France

  • Chru Angers

    Angers, France

  • Ch Côte Basque

    Bayonne, France

  • Ch Blois

    Blois, France

  • Bordeaux

    Bordeaux, France

  • Chalon Sur Saone

    Chalon-sur-Saône, France

  • Chu Dijon

    Dijon, France

  • Ch Dunkerque

    Dunkirk, France

  • Chu Grenoble

    Grenoble, France

  • Chd Vendée

    La Roche-sur-Yon, France

  • Chru Lille

    Lille, France

  • Chu Lyon

    Lyon, France

  • Lyon Sud

    Lyon, France

  • Ipc Marseille

    Marseille, France

  • Chr Metz

    Metz, France

  • Ch Mulhouse

    Mulhouse, France

  • Chu Nancy

    Nancy, France

  • Chu Nantes

    Nantes, France

  • Centre Antoine Lacassagne

    Nice, France

  • Institut Curie

    Paris, France

  • Chu Poitiers

    Poitiers, France

  • Chu Rennes

    Rennes, France

  • Ch Yves Le Foll

    Saint-Brieuc, France

  • René Huguenin

    Saint-Cloud, France

  • Chu Toulouse

    Toulouse, France

  • Chu Tours

    Tours, France

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Jul 2009
Primary completion
14 Dec 2010
Completion
14 Jul 2016
Last update posted
1 Apr 2021
Registered enrollment
143
Registry id
NCT00907452

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.